2005/934/EC: Commission Decision of  21 December 2005  amending Decisions 2004/696/EC and 2004/863/EC as regards the reallocation of the Community's financial contribution to the TSE eradication and monitoring programmes of the Member States for 2005  (notified under document number C(2005) 5564)
Date: 2005-12-21
Institutions: European Commission
Subjects: EU Member State, EU financing, action programme, animal disease, disease prevention, veterinary inspection

23.12.2005

EN

Official Journal of the European Union

L 340/73

COMMISSION DECISION

of 21 December 2005

amending Decisions 2004/696/EC and 2004/863/EC as regards the reallocation of the Community's
financial contribution to the TSE eradication and monitoring programmes of the Member States
for 2005

(notified under document number C(2005) 5564)

(2005/934/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

(4)

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Decision 90/424/EEC of 26 June
1990 on expenditure in the veterinary field (1), and in particular
Article 24(5) and (6) thereof,

Whereas:

(5)

(6)

The Community's financial contribution to certain of
those programmes therefore needs to be adjusted. It is
appropriate to reallocate funding from programmes of
Member States which are not using their full allocation
to those that are exceeding it. The reallocation should be
based on the most recent information on the expenditure
actually incurred by the concerned Member States.

Decisions
therefore be amended accordingly.

2004/696/EC and

2004/863/EC should

The measures provided for
accordance with
Committee on the Food Chain and Animal Health,

in this Decision are in
Standing
the

opinion

the

of

Commission Decision 2004/696/EC of 14 October 2004
on the list of programmes for the eradication and the
monitoring of certain TSEs qualifying for a financial
contribution from the Community in 2005 (2), lists the
submitted to the Commission by the
programmes
Member States for the eradication and monitoring of
transmissible
(TSE)
qualifying for a Community financial contribution in
the proposed rate
2005. That Decision also sets out
and maximum amount of
the contribution for each
programme.

spongiform encephalopathies

HAS ADOPTED THIS DECISION:

Article 1

The Annexes
accordance with the Annex to this Decision.

to Decision 2004/696/EC are amended in

Article 2

Decision 2004/863/EC is amended as follows:

Commission Decision 2004/863/EC of 30 November
2004 approving the TSE eradication and monitoring
programmes of certain Member States for 2005 and
fixing the level of
the Community's financial contri-
bution (3), approves the programmes which are listed in
Decision 2004/696/EC and lays down the maximum
amounts of the Community's financial contribution.

1. In Article 7(2),
8 536 000’;

2. In Article 10(2),
8 397 000’;

‘EUR 8 846 000’

is replaced by ‘EUR

‘EUR 8 677 000’

is replaced by ‘EUR

Decision 2004/863/EC also provides for reports on the
progress of the TSE monitoring programmes and the
costs paid, to be forwarded by the Member States to
the Commission every month. An analysis of
those
reports indicates that certain Member States will not
utilise their full allocation for 2005, while others will
spend in excess of the allocated amount.

(1) OJ L 224, 18.8.1990, p. 19. Decision as last amended by Directive
the Council

the European Parliament and of

2003/99/EC of
(OJ L 325, 12.12.2003, p. 31).

3. In Article 11(2),

503 000’;

‘EUR 353 000’

is

replaced by ‘EUR

4. In Article 16(2),
4 840 000’;

5. In Article 18(2),
1 540 000’;

‘EUR 4 510 000’

is replaced by ‘EUR

‘EUR 1 480 000’

is replaced by ‘EUR

(2) OJ L 316, 15.10.2004, p. 91. Decision as amended by Decision

2005/413/EC (OJ L 141, 4.6.2005, p. 24).

(3) OJ L 370, 17.12.2004, p. 82. Decision as amended by Decision

2005/413/EC.

6. In Article 21(2),

363 000’;

‘EUR 313 000’

is

replaced by ‘EUR

(1)

(2)

(3)

L 340/74

EN

Official Journal of the European Union

23.12.2005

7. In Article 24(2),

100 000’;

8. In Article 25(2),
3 350 000’;

9. In Article 26(2),

80 000’;

‘EUR 250 000’

is

replaced by ‘EUR

‘EUR 2 500 000’

is replaced by ‘EUR

‘EUR 200 000’

is

replaced by ‘EUR

10. In Article 28(2), ‘EUR 25 000’ is replaced by ‘EUR 20 000’;

11. In Article 29(2),

20 000’;

12. In Article 31(2),

310 000’;

13. In Article 35(2),

30 000’;

14. In Article 36(2),

460 000’;

‘EUR 150 000’

is

replaced by ‘EUR

‘EUR 500 000’

is

replaced by ‘EUR

‘EUR 150 000’

is

replaced by ‘EUR

‘EUR 450 000’

is

replaced by ‘EUR

15. In Article 37(2), ‘EUR 10 000’ is replaced by ‘EUR 25 000’;

20. In Article 49(2),

865 000’;

21. In Article 50(2),
9 035 000’;

22. In Article 51(2),
2 400 000’;

23. In Article 54(2),
5 075 000’;

‘EUR 1 555 000’

is replaced by ‘EUR

‘EUR 9 525 000’

is replaced by ‘EUR

‘EUR 1 300 000’

is replaced by ‘EUR

‘EUR 5 565 000’

is replaced by ‘EUR

24. In Article 58(2), ‘EUR 5 000’ is replaced by ‘EUR 55 000’;

25. In Article 59(2),

755 000’;

26. In Article 61(2),

915 000’;

‘EUR 575 000’

is

replaced by ‘EUR

‘EUR 695 000’

is

replaced by ‘EUR

27. In Article 64(2), ‘EUR 5 000’ is replaced by ‘EUR 25 000’.

16. In Article 38(2),

845 000’;

‘EUR 975 000’

is

replaced by ‘EUR

This Decision is addressed to the Member States.

Article 3

17. In Article 39(2), ‘EUR 25 000’ is replaced by ‘EUR 10 000’;

18. In Article 41(2), ‘EUR 25 000’ is replaced by ‘EUR 10 000’;

19. In Article 45(2),

120 000’;

‘EUR 20 000’

is

replaced by ‘EUR

Done at Brussels, 21 December 2005

For the Commission

Markos KYPRIANOU
Member of the Commission

23.12.2005

EN

Official Journal of the European Union

L 340/75

Annexes I, II and III to Decision 2004/696/EC are replaced by the following:

ANNEX

‘ANNEX I

List of programmes for the monitoring of TSEs

Rate and maximum amount of the Community financial contribution

Disease

Member State

Rate tests performed (1)

Maximum amount

(in EUR)

TSEs

Austria

Belgium

Cyprus

Czech Republic

Denmark

Estonia

Finland

France

Germany

Greece

Hungary

Ireland

Italy

Lithuania

Luxembourg

Malta

Netherlands

Portugal

Slovenia

Spain

Sweden

United Kingdom

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

100 %

2 076 000

3 586 000

503 000

1 736 000

2 426 000

294 000

1 170 000

29 755 000

15 170 000

1 487 000

1 184 000

6 172 000

8 397 000

836 000

155 000

36 000

4 840 000

1 540 000

444 000

8 536 000

363 000

5 690 000

(1) Rapid tests and primary molecular tests.

Total

96 396 000

L 340/76

EN

Official Journal of the European Union

23.12.2005

ANNEX II

List of programmes for the eradication of BSE

Maximum amount of the Community financial contribution

Disease

Member State

Rate

Maximum amount

(in EUR)

BSE

Austria

Belgium

Cyprus

Czech Republic

Denmark

Estonia

Finland

France

Germany

Greece

Ireland

Italy

Luxembourg

Netherlands

Portugal

Slovak Republic

Slovenia

Spain

United Kingdom

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

50 % culling

25 000

100 000

25 000

3 350 000

80 000

20 000

10 000

310 000

875 000

20 000

4 000 000

205 000

30 000

460 000

845 000

25 000

10 000

1 320 000

4 235 000

Total

15 945 000

23.12.2005

EN

Official Journal of the European Union

L 340/77

ANNEX III

List of programmes for the eradication of scrapie

Maximum amount of the Community financial contribution

Disease

Member State

Rate

Maximum amount

(in EUR)

Scrapie

Austria

Belgium

Cyprus

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

Czech Republic

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

50 % culling; 100% genotyping

50 % culling; 100% genotyping

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

2 485 000

10 000

105 000

5 075 000

120 000

5 000

10 000

25 000

2 400 000

2 275 000

865 000

55 000

800 000

5 000

5 000

35 000

755 000

915 000

340 000

65 000

Slovak Republic

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

50 % culling; 100 % genotyping

9 035 000

50 % culling; 100 % genotyping

10 000

United Kingdom

50 % culling; 100 % genotyping

Total

7 380 000

32 775 000’

Denmark

Estonia

Finland

France

Germany

Greece

Hungary

Ireland

Italy

Latvia

Lithuania

Luxembourg

Netherlands

Portugal

Slovenia

Spain

Sweden